1. Home
  2. Labeler Index
  3. Proficient Rx Lp
  4. 63187-148
  5. Product Images: Gabapentin

Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Gabapentin NDC 63187-148 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - gabapentin fig1

Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - gabapentin fig1

Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - gabapentin fig2

Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - gabapentin fig2

This is a chart displaying the mean pain score over a period of 7 weeks, with a 3-week dose titration period, a 4-week fixed dose period, and three different groups: a placebo group, a group taking 1800mg/day of gabapentin, and a group taking 2400mg/day of gabapentin. The chart shows that the gabapentin groups had a significantly lower mean pain score compared to the placebo group (p<0.001).*

Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin fig3

Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin fig3

This text appears to be displaying some statistical data related to two studies. The "Percentage of Responders at Endpoint" is shown. Two p-values are given, one less than 0.01 and another less than 0.0001. The names of the studies (Study 1 and Study 2) are also mentioned.*

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig4

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig4

Gabapentin 800mg - gabapentin fig5

Gabapentin 800mg - gabapentin fig5

This is a description of a medication identified as Gabapentin 800mg. The medication comes in a bottle with 90 biconvex, elliptical, white, film-coated tablets, and each tablet contains Gabapentin USP 800mg. The tablets have a break line on both sides with ‘D’ and ‘25’ on either side of the break line on one side and plain on the other side. The NDC for the medication is 63187-148-90, and the product ID is PG014890. It is RX-only medication manufactured by Aurobindo Pharma Limited Unit-VII in India. The medication should be stored at 20°-25°C (68°-77°F), and it is important to keep it out of the reach of children. The lot number is 00000, and the expiration date is 00/00/00. The medication was packaged by Proficient Rx LP in Thousand Oaks, CA 91320.*

Chemical Structure - gabapentin str

Chemical Structure - gabapentin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.